tirzepatide and hair thinning Does Cause Loss? hair loss due to tirzepatide

Researchers have observed that patients prescribed semaglutide, the active ingredient in both drugs, had an increased risk of nonarteritic anterior ischemic optic neuropathy (NAION)

The drug carries a potential risk for a type of thyroid tumor, so it shouldnt be taken by people with a personal or family history of certain thyroid and endocrine tumors

Complete semaglutide dosage chart for 2mg per mL concentration The 2mg/mL concentration is less common but sometimes preferred by people who want very large unit measurements for maximum accuracy

Science 352 , 712716

Additional Considerations Clinical trials are carefully controlled, which means they may not capture every possible side effect that could occur in the real world

Starting with Purity: This is where we come in